Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M D Manhart"'
Autor:
Robert Lindsay, M. D. Manhart, I P Barton, Cyrus Cooper, Tjeerd-Pieter van Staa, Richard Eastell, Jonathan D. Adachi, Nelson B. Watts
Publikováno v:
JOURNAL OF CLINICAL DENSITOMETRY. 7(3)
Low bone mineral density (BMD) is correlated with increased fracture risk. Whether greater BMD increases induced by osteoporosis drugs are related to greater decreases in fracture risk is controversial. We analyzed the relationship between BMD change
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0399c7bc43464760a52c269e6168a1
http://ora.ox.ac.uk/objects/uuid:1d8fa04c-8bf7-4463-b90e-0215dbb5878b
http://ora.ox.ac.uk/objects/uuid:1d8fa04c-8bf7-4463-b90e-0215dbb5878b
Autor:
Babul Borah, Paula A. Chmielewski, Thomas Edward Dufresne, M. D. Manhart, Chines Arkadi Aaron, T. D. Johnson
Publikováno v:
Bone. 34(4)
The deterioration of trabecular microarchitecture induced by elevated bone turnover is increasingly recognized as a factor in the pathogenesis of osteoporotic fractures. We investigated the effect of the reduction of turnover with risedronate on trab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbac165793ab6b58ad681870424d99c
https://pubmed.ncbi.nlm.nih.gov/15050906
https://pubmed.ncbi.nlm.nih.gov/15050906
Autor:
Rodney A. Hughes, Robert G. Josse, I P Barton, M. D. Manhart, Nelson B. Watts, Ronald C. Hamdy, Dieter Felsenberg, Danny Calligeros
Publikováno v:
The Journal of clinical endocrinology and metabolism. 88(2)
Independent risk factors for fracture include advanced age, preexisting fractures, and low bone mineral density. Rised-ronate has been shown in several large trials to be safe and effective for patients with osteoporosis, but its effects in populatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717d75691c47721d8b4604a20a7218cf
https://pubmed.ncbi.nlm.nih.gov/12574176
https://pubmed.ncbi.nlm.nih.gov/12574176
Publikováno v:
Calcified tissue international. 73(5)
Risedronate reduces the risk of vertebral fractures by up to 70% within the first year of treatment. Increases in bone mineral density or decreases in bone turnover markers explain only a portion of the anti-fracture effect, suggesting that other fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112f3b20638a9f814686f6308290074b
https://pubmed.ncbi.nlm.nih.gov/12964065
https://pubmed.ncbi.nlm.nih.gov/12964065
Autor:
H, Soriano-Brücher, P, Avendaño, M, O'Ryan, S D, Braun, M D, Manhart, T K, Balm, H A, Soriano
Publikováno v:
Pediatrics. 87(1)
Bismuth subsalicylate (BSS) and placebo were evaluated in a double-blind, placebo-controlled study as adjunct to rehydration therapy in 123 children, aged 4 to 28 months, hospitalized with acute diarrhea. The dosing regimen was 20 mg/kg five times da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d64d0a2342c76e9fc01f3edea833fc9b
https://pubmed.ncbi.nlm.nih.gov/1984613
https://pubmed.ncbi.nlm.nih.gov/1984613
Autor:
M. D. Manhart
Publikováno v:
Reviews of infectious diseases. 12
This report demonstrates that bismuth subsalicylate (BSS) effectively inhibits growth of a number of bacterial strains known to cause diarrhea, including Escherichia coli, Salmonella, Shigella, and Campylobacter. Other bismuth salts and sodium salicy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ac0981d0c2a876c1a4ea4fd1483a69
https://pubmed.ncbi.nlm.nih.gov/2406851
https://pubmed.ncbi.nlm.nih.gov/2406851
Publikováno v:
Antimicrobial Agents and Chemotherapy. 29:625-627
In a randomized double-blind study, Swiss adults traveling to tropical countries for 12 to 28 days took a solid formulation of bismuth subsalicylate (1.05 or 2.1 g/day on a twice-daily regimen) or placebo. Efficacy was evaluated in 231 volunteers. Di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec959775cd48708675966f4d475a5ccf
https://doi.org/10.1128/aac.29.4.625
https://doi.org/10.1128/aac.29.4.625
Pseudomonas exotoxin A enters mouse LM fibroblasts by receptor-mediated endocytosis and ultimately causes cell death. Here we present evidence for the existence of a specific receptor for the toxin. Toxin association with LM cells at 18 and 37 degree
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3057c0b2f6397c663f5e46d3c45dbd13
https://europepmc.org/articles/PMC263336/
https://europepmc.org/articles/PMC263336/
Autor:
E. Grossman, M. D. Manhart, R. L. Isaacs, B. W. Bollmer, G. A. Ferretti, O. P. Sturzenberger, A. H. Meckel, R. C. Lijana, D. J. Moore
Publikováno v:
Journal of periodontology. 60(8)
This study compared the clinical efficacy of three mouthrinses containing either 0.12% chlorhexidine, phenolic compounds, or sanguinarine, which were used unsupervised, in a placebo-controlled, double-blind study of 6 months' duration. The study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f56d0d66e95bc0cf07d1df638b0aa7ef
https://pubmed.ncbi.nlm.nih.gov/2352109
https://pubmed.ncbi.nlm.nih.gov/2352109
Clustering of ligands into coated regions of the plasma membrane is an early step in receptor-mediated endocytosis. The association of Pseudomonas exotoxin A (PE) with mouse LM fibroblasts was visualized by using biotinyl-PE and avidingold. Movement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d97ce490a872295b39eda5f64d9034
https://europepmc.org/articles/PMC264925/
https://europepmc.org/articles/PMC264925/